Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.14 - $135.6 $176,182 - $171 Million
-1,258,447 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$0.54 - $2.51 $568,944 - $2.64 Million
1,053,600 Added 514.34%
1,258,447 $674,000
Q3 2021

Nov 12, 2021

BUY
$1.54 - $3.04 $11,941 - $23,572
7,754 Added 3.93%
204,847 $346,000
Q2 2021

Aug 13, 2021

BUY
$2.2 - $3.2 $433,604 - $630,697
197,093 New
197,093 $510,000

About Aditxt, Inc.


  • Ticker ADTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,161,130
  • Market Cap $749K
  • Description
  • Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...
More about ADTX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.